Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) SHH

9.32

-0.16(-1.69%)

Updated at June 03 11:29AM

Currency In CNY

Valuation

Market Cap8.21B
Enterprise Value7.53B
P/E Ratio71.26
PEG Ratio-1.48
Price/Sales Ratio9.75
Price/Book Ratio3.25
Enterprise/Revenue9.04
Enterprise/EBITDA46.69

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.14
Operating Margin0.16

Management Effectiveness

Return On Assets0.03
Return On Equity0.05

Income Statement

Revenue786.77M
Revenue/Share0.96
Gross Profit399.13M
EBITDA186.99M
Net Income130.57M
Diluted EPS0.16

Balance Sheet

Total Cash1.15B
Total Cash/Share1.4
Total Debt586.98M
Total Debt/Equity0.25
Current Ratio2.64
Book Value Per Share2.87

Price History

52-Week Change-0.21
52-Week High12.51
52-Week Low8.48
Moving Average 50 Days10.01
Moving Average 200 Days10.03

Statistics

Average Volume10.74M
Shares Outstanding830.3M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield1.07
Payout Ratio0.78
Last Split Factor7:5
Last Split DateJuly 12, 2024